Galderma's $978M Bid Falls Short With Q-Med Investors
Just 54 percent of Sweden-based Q-Med's shareholders accepted the $11.70 (75 kronor) per share bid, far below the 90 percent threshold Galderma said was required, company said, adding it would announce its next move on Feb. 10.
Q-Med issued a statement dated Monday, saying there was no interest from other potential buyers. Q-Med also said the statement was...
To view the full article, register now.